ABRF-PRG05: de novo peptide sequence determination.

Arnold M. Falick(Howard Hughes Medical Institute), Thomas A. Neubert(New York University), Brett S. Phinney(University of California, Davis), Jeffrey A. Kowalak(National Institute of Mental Health), Karen A. West, Susan T. Weintraub(The University of Texas at San Antonio Health Science Center), William S. Lane(Brigham and Women's Hospital), Christoph W. Turck(Kunming Institute of Zoology)
PubMed
September 1, 2008
Cited by 7

Related Papers

HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O <sub>2</sub> Sensing
|Science|2001|4.7k
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
|Cell|1997|4.5k
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
|Nature|1994|2.1k
Inhibition of Proteasome Activities and Subunit-Specific Amino-Terminal Threonine Modification by Lactacystin
|Science|1995|1.6k
Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation
|Journal of Biological Chemistry|2003|969